Researchers have used artificial intelligence to design viral sequences that do not occur naturally, raising new questions about biosecurity and the dual-use potential of AI in biological research. The development highlights both the accelerating capabilities of AI systems in molecular design and the emerging challenges for safety oversight in synthetic biology.
Why it matters: As AI becomes increasingly capable of generating novel biological sequences, tech and policy leaders must grapple with biosecurity implications and the need for responsible AI governance in high-risk domains.